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Abstract
A clinical case study of high-intensity focused ultrasound (HIFU) treatment
in the uterine fibroid was conducted. During the therapy, poor heating effi-
cacy was observed which could be attributed to several factors such as the
local perfusion rate, patient-specific anatomy or changes in acoustic parame-
ters of the ultrasound field. In order to determine the cause of the diminished
heating, perfusion analyses and ultrasound simulations were conducted us-
ing the magnetic resonance imaging (MRI) data from the treatment. The
perfusion analysis showed high local perfusion rate in the myoma (301.0 ±
25.6 mL/100 g/min) compared to the surrounding myometrium (233.8 ±
16.2 mL/100 g/min). The ultrasound simulations did not show large differ-
ences in the focal point shape or the acoustic pressure (2.07 ± 0.06 MPa)
when tilting the transducer. However, a small shift (−2.2 ± 1.3 mm) in the
axial location of the focal point was observed. The main causes for the dimin-
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ished heating were likely the high local perfusion and ultrasound attenuation
due to the deep location of the myoma.
c© 2019 IEEE.
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Introduction
High-intensity focused ultrasound (HIFU) therapy is a non-invasive treat-
ment method which can be used to treat uterine fibroids (i.e., myomas) (Kim
et al., 2011). The clinical treatment of patients with uterine fibroids using
HIFU therapy is nowadays a standard practice, but the outcome of the treat-
ment is sometimes unsuccessful due to the diminished heating efficacy in the
target region (Thiburce et al., 2015). The lower heating effect in some pa-
tients can be attributed to several factors such as the local perfusion rate,
the location and depth of the myoma, and the attenuation of ultrasound en-
ergy (Rueff and Raman, 2013; Kim et al., 2014; Wang et al., 2016; Suomi
et al., 2018). Furthermore, in some cases the transducer has to be positioned
at an angle in order to avoid intervening tissue structures or to reach deep-
laying targets (Sainio et al., 2018). All of these effects reduce the heating
efficacy resulting in a poor response to the HIFU treatment.
The aim of this study was to investigate how local perfusion, transducer
positioning and patient-specific anatomy affect the treatment efficacy. For
this purpose, a retrospective clinical case study of HIFU treatment in the
uterine fibroid with diminished heating was conducted. Magnetic resonance
imaging (MRI) was used to determine the patient anatomy as well as to quan-
tify the local perfusion rate of the myoma. Furthermore, three-dimensional
ultrasound simulations were conducted on the segmented MR-image data in
order to evaluate the effect of transducer orientation and patient anatomy
on the acoustic parameters of the ultrasound focal point. The results iden-
tify the main factors affecting the treatment outcome, which helps avoiding
similar cases in the future.
3
Clinical case
The study was retrospective using the patient data from a uterine fibroid
HIFU treatment conducted at the Turku University Hospital, Finland. Ethi-
cal permission for the usage of the patient data (ETMK: 152/1801/2016) was
obtained from the Ethics Committee of Hospital District of Southwest Fin-
land. All patient records collected for the study were anonymised prior using
the data. The experimental procedures involving human subjects described
in this paper were approved by the Institutional Review Board.
The patient was 40 years old with no history of pregnancies or previous
uterine fibroid treatments. She had been diagnosed with a single 59 mL intra-
muscular leiomyoma located in the lateral myometrium. In the pre-treatment
T2w-MRI scan (see Fig. 1), the fibroid was hypointense when compared to
the myometrium with the signal intensity values of 66.6, 224.9 and 175.6 for
abdominal muscle, myometrium and myoma, respectively. In the gadolinium-
(a) (b)
Figure 1: (a) Axial and (b) sagittal T2w-MR images of the myoma from the pre-treatment
screening scan. The fibroid appeared hypointense when compared to the myometrium.
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enhanced contrast scan, the fibroid was markedly hyperintense with respect
to myometrium during the arterial phase, but hypointense during the venous
phase. In addition to MRI examination, partial resection was performed
to obtain tissue sample and confirm the diagnosis of benign uterine fibroid.
During the resection, tissue was also found to be highly vascularised.
The patient was treated using a clinical HIFU therapy system (Sonalleve
V2, Profound Medical, Mississauga, Canada). During the HIFU therapy,
adequate heating was not observed (the highest temperature was 55.4 ◦C)
despite using 300 W of acoustic power which is the maximum allowed by
the therapy system. Factors that could potentially contribute to the poor
heating during the therapy include: (i) high perfusion rate of the tissue, (ii)
the rotation of the transducer during the sonications, and (iii) the use of
wedge-shaped gel pad to manipulate the patient anatomy.
In the post-therapy MRI scans, decent non-perfused volume (NPV) ratio
(i.e., the ratio of the ablated volume to that of the myoma) was observed in
the initial contrast-enhanced MRI, although it markedly decreased during 10-
minute dynamic scanning and was measured to be 2.7% in the post-therapy
scan. NPV ratio less than 30% has been shown to indicate sub-optimal
treatment outcome in terms of symptom severity score (Fennessy et al., 2007).
The patient was admitted to surgical reintervention less than a month after
the therapy.
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Table 1: Perfusion imaging parameters
Parameter Value Parameter Value
Sequence e-THRIVE Repetition time 2.93 ms
Fat saturation SPAIR Echo time 1.31 ms
Imaging Plane Axial Temporal resolution 4.18 ms
Flip angle 10◦
Section thickness 3 mm
Field of view 270 × 350 × 120 mm3
Methods
Perfusion analysis
Pre-treatment MRI scans of the patient were performed four months be-
fore the HIFU treatment using a 3T MRI system (Ingenia, Philips Healthcare,
Best, the Netherlands) with a 32-channel array torso coil.
The MRI protocol comprised of dynamic contrast enhanced (DCE) T1-
weighted sequence with parameters shown in the Table 1. A single dose
(0.2 mL/kg) of contrast agent (Dotarem, Guebert, Roissy, France) was in-
jected at constant rate followed by 10 mL saline flush after the acquisition
of five dynamic scans.
DCE-MRI data were analysed with NordicICE perfusion analysis soft-
ware (v. 4.1.1, NordicNeuroLab AS, Bergen, Norway). First, the signal
was converted to change in 1/T1 relaxation rate. Baseline T1 mapping was
performed with inversion recovery technique. Arterial input function was
determined from iliac artery by placing a circular region of interest (ROI)
on the artery. The blood flow (i.e., the perfusion rate) was quantified by T1
perfusion deconvolution arithmetic with a first pass of arterial input func-
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tion curve. The perfusion values were obtained from the entire fibroid and
myometrium by averaging over three subsequent ROIs.
Ultrasound simulations
Three-dimensional ultrasound simulations were conducted using the pa-
tient MRI data acquired during the HIFU treatment (see Fig. 2(a)). The
image data were segmented into water/bladder, bone, muscle, fat and my-
oma tissues (see Table 2 for acoustic properties (Mast, 2000; Keshavarzi et al.,
2001; Hasgall et al., 2015)). The simulations were conducted on the HIFU
therapy system which had an annular transmitting surface of outer diameter
12.0 cm, inner hole diameter 4.0 cm, sonication frequency 1.2 MHz and focal
length 14.0 cm. The simulations were linear with the computational grid
supporting frequencies up to 2.0 MHz and they were carried out using the
parallelised C++ version of the open source k-Wave Toolbox (Jaros et al.,
2016).
An illustration of the simulation geometry is presented in Fig. 2(b). The
transducer was positioned so that the geometric focal point of the transducer
was located in the bottom part of the myoma, which corresponded to the
actual treatment location. The transducer was rotated at different angles
around the left-right axis between 0 and −20 degrees relative to the target
location inside the myoma while keeping the focal point position constant.
Focal point deformation, maximum pressure values and focal shifts in axial,
lateral and elevation directions were characterised and the results were then
compared to the actual treatment outcome of the same patient.
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Table 2: Tissue acoustic properties for ultrasound simulations
Density Sound speed Attenuation
(kg/m3) (m/s) (dB/MHz1.1/cm)
Water/Bladder 1000 1520 0.00217
Bone 1908 3515 4.74
Muscle 1050 1547 1.09
Fat 950 1478 0.48
Myoma 1105 1611 0.90
(a) (b)
Figure 2: (a) MRI temperature map acquired during HIFU therapy shows poor heating
in the myoma when the transducer was tilted. (b) The three-dimensional simulation grid
segmented using the MR images. The transducer was rotated around the left-right axis
between 0 and −20 degrees with 5-degree steps while keeping the focal point position
inside the myoma (black cross) constant.
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Results
Perfusion analysis
Fig. 3(a) shows the pre-therapy perfusion map of the axial plane acquired
using DCE-MRI where the enhanced blood flow in the area of the uterine
fibroid is clearly visible. The corresponding perfusion values were 301.0 ±
25.6 and 233.8 ± 16.2 mL/100 g/min in the myoma and myometrium, re-
spectively. For reference, the perfusion rate of the gluteus maximus was 30.1
± 3.7 mL/100 g/min.
Fig. 3(b) shows the perfusion map after the therapy. The perfusion in
the fibroid was markedly decreased despite of the rather small NPV. In the
initial, arterial phase of the dynamic DCE-MRI NPV appeared quite decent,
however, it markedly decreased during the 10-minute dynamic scanning and
was measured only 2.7% in the post therapy scan. When looking at the
dynamic enhancement curves of the fibroid and normal myometrium before
and after the treatment (see Fig. 3(b) and (c)), it seems that this appearance
was caused by the rather slow uptake of the contrast agent with markedly
decreased arterial peak in the fibroid compared to the pre-treatment image.
This could be explained, for example, by a transient vasospasm caused by
the treatment.
Ultrasound simulations
Changing the transducer rotation angle between 0 and −20 degrees did
not have a large effect on the focal point shape where nearly ellipsoidal −6 dB
focal region of the same size was observed in all the cases (see Fig. 4(a)). The
focal volumes were approximately 18 mm in length and 3 mm in width and
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they had uniform isosurfaces. This suggests that the geometry of the ultra-
sound pathway through different tissue layers did not change considerably
in order to deform or split the focal point into smaller subvolumes. This
is partly because a large portion of the ultrasound pathway was inside the
bladder which has negligible effect on ultrasound attenuation and dispersion.
Similarly, the maximum pressures inside the focal points did not change
(a) (b)
(c) (d)
Figure 3: (a)-(b) Axial DCE-MRI perfusion maps before and after the HIFU therapy,
respectively, and (c)-(d) the corresponding signal intensity curves for the arterial input
function, myometrium and myoma. The perfusion rate of the fibroid was markedly de-
creased after the therapy.
10
noticeably with the average maximum pressure of 2.07 MPa and standard
deviation of ±0.06 MPa (see Fig. 4(b)). For reference, the maximum pres-
sure in water with the same output power was 4.49 MPa. Since focal point
deformation or splitting were not observed, the pressure distributions inside
the focal volumes also remained relatively constant with the maximum pres-
sure being in the centre of the focal volume. Only at 0 degrees of transducer
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Figure 4: (a) Colour-coded ultrasound focal points thresholded at −6 dB show the effect of
transducer rotation on its shape and location (0◦ magenta, −5◦ yellow, −10◦ red, −15◦
green, −20◦ blue). (b) The maximum pressure of the ultrasound field with respect to the
transducer rotation angle. (c) The shifts in the focal point location (i.e., the maximum
pressure) in axial, lateral and elevation directions with respect to the transducer rotation
angle.
11
rotation, a slight drop in the maximum pressure was observed. This is prob-
ably due to the fact that the portion of ultrasound waves travelling through
tissue is the greatest in this case, which results in high energy loss due to
attenuation. On the contrary, the portion of waves propagating through the
bladder is the smallest. The highest acoustic pressure (and thus, the heat-
ing efficacy) is achieved when the majority of ultrasound waves propagate
through the bladder.
The effect of rotation angle on the focal shift (i.e., the location of the
maximum pressure) was more pronounced (see Fig. 4(c)). In the axial, lateral
and elevation directions average focal shifts of −2.2 ± 1.3 mm, 0.5 ± 0.2 mm
and −1.0 ± 0.2 mm were observed, respectively. The simulation geometry
does not change in lateral direction due to the rotation which explains the
negligible shift in this direction. In elevation direction, the rotation angles
might not be extreme enough in order to induce larger shifts than observed
in the simulations. The axial shift can be attributed to the change in the
geometry which ‘pulls’ the focus towards the transducer at large rotation
angles due to refraction and phase velocity changes.
Discussion
An analysis of the factors affecting the heating efficacy during the HIFU
therapy was conducted. For the analysis, retrospective clinical data of a sin-
gle patient treated at the hospital for the uterine fibroid was used. Further-
more, DCE-MRI data was used for the perfusion analysis and patient-specific
ultrasound simulations were conducted in order to evaluate the changes in
acoustic parameters.
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Poor heating efficacy was observed during the HIFU therapy although the
maximum power allowed by the system was used. Rotating the transducer
diminished the heating effect even further. The end result was suboptimal
and the patient was thus admitted to a surgical reintervention less than a
month after the treatment.
During the therapy, a wedged gel pad was used to manipulate the myoma
location to an optimal position for the therapy. In theory, the asymmetric
shape of the gel pad related to the symmetry axis of the transducer could
generate phase shifts in the propagating ultrasound waves. This in turn
would deform or split the focal point at the target location and diminish the
heating effect (Suomi et al., 2018). However, the usage of the wedged gel pad
was not found to affect the focal point shape nor the acoustic parameters in
the simulations.
Similarly, changing the orientation of the transducer during the HIFU
treatment did not result in a considerable loss of therapeutic efficacy in terms
of the ultrasound focal point shape and acoustic pressure. The maximum
acoustic pressure was observed to stay approximately constant despite of
the rotation angle of the transducer. Likewise, the focal volume maintained
its ellipsoidal shape at different angles of transducer orientation. Only a
slight axial shift was observed when the rotation angle of the transducer
was increased. In practice, however, the observed shift would not affect the
therapy region since the thermal ablation volume is typically multiple times
larger compared to the ultrasound focal volume (Suomi et al., 2018).
The perfusion analysis showed enhanced blood flow in the region of the
myoma when compared to the surrounding myometrium. A high perfusion
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rate has a strong cooling effect which has been shown to be a significant
predictor of treatment outcome (Keserci and Duc, 2017). It has previously
been reported that the perfusion of the uterine fibroids varies on average
between 50-334 mL/100 g/min, which supports that the fibroid in this study
had relatively high perfusion rate (Wei et al., 2018). Furthermore, it has
been shown that in the prostate the perfusion rate significantly increases
during thermal exposure (van Vulpen et al., 2002), which could be the case
in the myoma as well. The cooling effect of perfusion could potentially be
diminished by the administration of oxytocin before the treatment (Lozinski
et al., 2018).
Conclusions
In the evaluation of the clinical treatment outcome, the changes in the
acoustic parameters of the ultrasound focal point did not seem to be the
major cause for the experienced poor heating efficacy. Other factors, such as
local perfusion, ultrasound attenuation and the location of the myoma, likely
played a more significant role in this case. However, these results might differ
when using another patient data, which still requires further research.
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